Administration of a Nondepleting Anti-CD4 Monoclonal Antibody (W3/25) Prevents Adjuvant Arthritis, Even upon Rechallenge: Parallel Administration of a Depleting Anti-CD8 Monoclonal Antibody (OX8) Does Not Modify the Effect of W3/25 (Q61472064)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 October 1995
edit
Language Label Description Also known as
English
Administration of a Nondepleting Anti-CD4 Monoclonal Antibody (W3/25) Prevents Adjuvant Arthritis, Even upon Rechallenge: Parallel Administration of a Depleting Anti-CD8 Monoclonal Antibody (OX8) Does Not Modify the Effect of W3/25
scientific article published on 01 October 1995

    Statements

    Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25 (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit